Literature DB >> 7610767

Distribution of neuronal growth-promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly.

S S Zhan1, W Kamphorst, W E Van Nostrand, P Eikelenboom.   

Abstract

In the present immunohistochemical study, we investigated the characteristics of altered neurites in the frontal cortex of 10 Alzheimer's disease (AD) brains and 15 age-matched non-demented control brains. In both AD and control cases, the altered neurites in coronas of the classical plaques (CP) were frequently immunostained by antibodies to growth-promoting factors, N and C termini of amyloid precursor protein (APP), GAP43, collagen IV, laminin and the integrin receptor VLA6. The altered neurites in CP coronas in AD but not in controls were also immunostained by antibodies against normally and abnormally phosphorylated tau. Immunolabeling for microtubule-associated protein 2 was not found in CP from either group. Extensive neuropil threads (NT) and many neurofibrillary tangles (NFT), immunostained with tau and Alz50 antibodies, were present in AD neocortex but not seen in control cases. NT and NFT could not be stained by antibodies to the N termini of APP, GAP43, collagen IV, laminin and VLA6. Our findings indicate that in AD cases altered neurites in CP are undergoing both an aberrant sprouting process and a degenerating process. These altered neurites are probably of axon origin. NT and NFT may represent destructive changes. The presence of amyloid plaques, but absence of tau-related cytoskeletal pathology, in non-demented cases suggests that beta/A4 peptide is necessary but not sufficient to induce neurofibrillary pathology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7610767     DOI: 10.1007/BF00309629

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  54 in total

Review 1.  Cytokines and inflammatory proteins in Alzheimer's disease.

Authors:  F Berkenbosch; J Biewenga; M Brouns; J M Rozemuller; P Strijbos; A M van Dam
Journal:  Res Immunol       Date:  1992 Jul-Aug

Review 2.  Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.

Authors:  K Iqbal; I Grundke-Iqbal
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

3.  B-50/GAP-43 in neuronal development and repair.

Authors:  W H Gispen; J Boonstra; P N De Graan; F G Jennekens; A B Oestreicher; P Schotman; L H Schrama; J Verhaagen; F L Margolis
Journal:  Restor Neurol Neurosci       Date:  1990-01-01       Impact factor: 2.406

4.  Amyloid beta-protein precursor accumulates in dystrophic neurites of senile plaques in Alzheimer-type dementia.

Authors:  M Shoji; S Hirai; H Yamaguchi; Y Harigaya; T Kawarabayashi
Journal:  Brain Res       Date:  1990-03-26       Impact factor: 3.252

5.  Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.

Authors:  P J Whitehouse; D L Price; A W Clark; J T Coyle; M R DeLong
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

6.  Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.

Authors:  J Bauer; S Strauss; U Schreiter-Gasser; U Ganter; P Schlegel; I Witt; B Yolk; M Berger
Journal:  FEBS Lett       Date:  1991-07-08       Impact factor: 4.124

7.  About the presence of paired helical filaments in dystrophic neurites participating in the plaque formation.

Authors:  M Barcikowska; H M Wisniewski; C Bancher; I Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

8.  Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

Authors:  F Tagliavini; G Giaccone; B Frangione; O Bugiani
Journal:  Neurosci Lett       Date:  1988-11-11       Impact factor: 3.046

9.  A special type of senile plaque, possibly an initial stage.

Authors:  A Probst; H Brunnschweiler; C Lautenschlager; J Ulrich
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

10.  Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

Authors:  D W Dickson; J Farlo; P Davies; H Crystal; P Fuld; S H Yen
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

View more
  11 in total

1.  Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.

Authors:  E B Mukaetova-Ladinska; F Garcia-Siera; J Hurt; H J Gertz; J H Xuereb; R Hills; C Brayne; F A Huppert; E S Paykel; M McGee; R Jakes; W G Honer; C R Harrington; C M Wischik
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.

Authors:  M M Verbeek; I Otte-Höller; J van den Born; L P van den Heuvel; G David; P Wesseling; R M de Waal
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 3.  Mechanisms of synapse and dendrite maintenance and their disruption in psychiatric and neurodegenerative disorders.

Authors:  Yu-Chih Lin; Anthony J Koleske
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

4.  Contingent vulnerability of entorhinal parvalbumin-containing neurons in Alzheimer's disease.

Authors:  A Solodkin; S D Veldhuizen; G W Van Hoesen
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

5.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

Review 6.  The significance of neuroinflammation in understanding Alzheimer's disease.

Authors:  P Eikelenboom; R Veerhuis; W Scheper; A J M Rozemuller; W A van Gool; J J M Hoozemans
Journal:  J Neural Transm (Vienna)       Date:  2006-10-13       Impact factor: 3.575

7.  Increased matrix metalloproteinase 9 activity in mild cognitive impairment.

Authors:  Martin A Bruno; Elliott J Mufson; Joanne Wuu; A Claudio Cuello
Journal:  J Neuropathol Exp Neurol       Date:  2009-12       Impact factor: 3.685

8.  High plasticity of axonal pathology in Alzheimer's disease mouse models.

Authors:  Lidia Blazquez-Llorca; Susana Valero-Freitag; Eva Ferreira Rodrigues; Ángel Merchán-Pérez; J Rodrigo Rodríguez; Mario M Dorostkar; Javier DeFelipe; Jochen Herms
Journal:  Acta Neuropathol Commun       Date:  2017-02-07       Impact factor: 7.801

9.  Plasma protein profiling of Mild Cognitive Impairment and Alzheimer's disease using iTRAQ quantitative proteomics.

Authors:  Fei Song; Anne Poljak; Nicole A Kochan; Mark Raftery; Henry Brodaty; George A Smythe; Perminder S Sachdev
Journal:  Proteome Sci       Date:  2014-01-17       Impact factor: 2.480

Review 10.  Defining the earliest pathological changes of Alzheimer's disease.

Authors:  James C Vickers; Stan Mitew; Adele Woodhouse; Carmen M Fernandez-Martos; Mathew T Kirkcaldie; Alison J Canty; Graeme H McCormack; Anna E King
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.